Rate of acute adverse events for narrow-band UVB and Psoralen-UVA phototherapy

Photodermatology Photoimmunology and Photomedicine

Volumn 23, Issue 2-3, 2007, Pages 68-72

  Martin, J A ^a   Laube, S ^b   Edwards, C ^c   Gambles, B ^a   Anstey, A V ^c  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

Adverse events; Phototherapy; UVA; UVB

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; METHOXSALEN; PSORALEN; SUNSCREEN;

ARTICLE; BLISTER; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SAFETY; ERYTHEMA; FOOT; HAND; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; RETROSPECTIVE STUDY; SKIN DISEASE; SKIN EDEMA; SKIN TOXICITY; SUNBURN; THERAPEUTIC ERROR; TREATMENT DURATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

DERMATOLOGY; HUMANS; IATROGENIC DISEASE; MEDICAL AUDIT; MEDICAL RECORDS; PUVA THERAPY; RETROSPECTIVE STUDIES; SKIN DISEASES; STATE MEDICINE; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY; WALES;

EID: 34249799578     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2007.00278.x     Document Type: Article

References (23)

1. Ibbotson SH, Bilsland D, Cox NH, et al. An update and guidance on narrowband ultraviolet B phototherapy: A British photodermatology group workshop report. Br J Dermatol 2004; 151: 283-297.
2. Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: A report of a workshop of the British photodermatology group. Br J Dermatol 2000; 142: 22-31.
3. British photodermatology group guidelines for PUVA. Br J Dermatol 1994; 130: 246-55.
4. Taylor DK, Anstey AV, Coleman AJ, et al. Guidelines for dosimetry and calibration in ultraviolet radiation therapy: A report of a British photodermatology group workshop. Br J Dermatol 2002; 146: 755-763.
5. Green C, Feguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988; 119: 691-696.
6. Coven TR, Burack LH, Gilleaudeau P, et al. Narrow-band UV-B produces superior clinical and histopathological resolution of moderate- to - severe psoriasis in patients compared with broad-band UV-B. Arch Dermatol 1997; 133: 1514-1522.
7. Gordon PM, Biffey BL, Matthews JNS, Farr PM. A randomised comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999; 41: 728-732.
8. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. Etretinate (re-TL-01) vs. Etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992; 127: 5-9.
9. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992; 127: 509-512.
10. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: Three times or five times weekly treatment? Br J Dermatol 1998; 138: 833-839.
11. Wainwright NJ, Dawe RS, Feguson J. Narrow-band ultraviolet B (TL-01) phototherapy for psoriasis: Which incremental regimen? Br J Dermatol 1998; 139: 410-414.
12. Gupta G, Long J, Tillman DM. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol 1999; 140: 887-890.
13. Bilsland D, Gerage SA, Gibbs NK, et al. A comparison of narrow-band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993; 129: 708-712.
14. Perna JJ, Mannix ML, Rooney JF, et al. Reactivation of latent herpes simplex virus infection by ultraviolet light: A human model. J Am Acad Dermatol 1987; 17: 473-478.
15. Komericki P, Fellner P, El-Shabrawi Y, Ardjomand N. Keratopathy after ultraviolet B phototherapy. Wien Klin Wochenscher 2005; 117: 300-302.
16. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: A cooperative clinical trial. J Invest Dermatol 1977; 68: 328-335.
17. Morison WL, Marwaha S, Beck L. PUVA-induced phototoxicity: Incidence and causes. J Am Acad Dermatol 1997; 36: 183-185.
18. Lowe NJ, Weingarten D, Bourget T, Moy LS. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol 1986; 14: 754-760.
19. Collins P, Rogers S. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 1992; 127: 392-395.
20. Calzavara-Pinton PG, Ortel B, Honigsmann H, et al. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 1994; 189: 256-259.
21. Hannuksela M, Karvonen J. Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol 1978; 99: 703-707.
22. Takashima A, Yamamoto K, Kimura S, et al. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA. Br J Dermatol 1991; 124: 37-42.
23. Drummond A, Kane D, Bilsland Legal claims in Scottish national health service dermatology departments 1989-2001. Br J Dermatol 2003; 149: 111-114.